While our study cohorts were stratified by IDH status, we performed multivariate analysis to attempt to control for additional potential confounders including age, MGMT methylation, TMZ treatment, and chromosomal abnormalities commonly found in glioma. The gene discussed is IDH1; the disease is central nervous system cancer.